Immunology articles for France

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 137

Article ‘Count’ for Immunology.

Journal Count Share
1 0.73
Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model 0.73
3 0.55
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’) 0.03
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome 0.49
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus 0.03
2 1.64
Lifelong evolution of autoreactive plasma cell numbers, affinity and anatomical location in arthritic K/BxN mice 1.00
Comparative efficacy and safety of anakinra and canakinumab in patients with scpVEXAS/scp syndrome – an international multicenter study 0.64
7 2.34
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis 0.11
The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Csa/Csb red cell antigens 0.88
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis 0.07
Deciphering opsonized zymosan-induced phosphorylation of p47phox and NADPH oxidase activation in human neutrophils 1.00
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy 0.03
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study 0.06
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study 0.19
1 0.02
Altered T-cell reactivity in the early stages of Alzheimer's disease 0.02
2 0.89
Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells 0.14
Centromeric DNA amplification triggered by viral proteins activates nuclear cGAS 0.75
1 0.07
Long-chain unsaturated fatty acids released during immune responses stimulate host-microbe trans-kingdom communication 0.07
2 0.50
HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance. 0.05
Characterizing the Immune Response in Pig-to-human Heart Xenografts Using a Multimodal Diagnostic System. 0.45
2 1.11
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients 0.11
Cytomegalovirus Vertical Transmission Rate According to IgG Avidity Value and Valacyclovir Treatment of Maternal Primary Infection in the First Trimester of Pregnancy 1.00
1 0.04
Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With Sepsis. 0.04
1 0.40
Generalizability of Progression Risk in the TN-10 Trial to a European Population With or Without a First-Degree Relative With Type 1 Diabetes. 0.40
1 0.03
Neutrophil extracellular traps and peptidylarginine deiminase 4–mediated inflammasome activation link diabetes to cardiorenal injury and heart failure 0.03
1 1.00
Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes 1.00
1 0.11
Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance 0.11
1 0.25
Genomic regulatory landscape underlying the antiviral response of Atlantic salmon 0.25
1 1.00
Mumps virus infection triggers early pro-inflammatory responses and impairs Leydig and Sertoli cell function in an iex vivo/i human testis model 1.00
2 1.69
B cell-intrinsic IL-2 signaling regulates inflammation by promoting IL-10 expression in CD25+ age-associated B cells 1.00
The transcription factor NFIL3 drives innate lymphoid cell specification from lymphoid progenitors 0.69
3 1.62
Interferon Stimulatory DNA activates the DNA damage signaling through ATM and DNA-PK sensing 1.00
Surface emergence and persistence of MHC class I free heavy chains 0.40
The ability of SAMHD1-deficient monocytes to trigger the Type I IFN response depends on cGAS and mitochondrial DNA 0.22
3 1.62
Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation 0.07
Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes 0.71
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejection 0.84
12 3.12
Hypoxia-inducible protein 2 mediates metabolic adaptation of Ly6ChighLy6Glow monocytes after stroke 0.02
The STING HAQ haplotype and clinical non-penetrance in COPA syndrome 0.91
DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells 0.06
Claudin 1–mediated positioning of DC1 to mTECs is essential for maintenance of central tolerance 0.04
A circadian checkpoint relocates neutrophils to minimize injury 0.09
<atl>SpeckSeq enables high-throughput functional stratification of iMEFV/i variants in autoinflammatory diseases</atl> 0.82
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection 0.15
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action 0.09
TLR2 supports γδ T cell IL-17A response to ocular surface commensals by metabolic reprogramming 0.03
S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum 0.15
A CARMIL2 gain-of-function mutation suffices to trigger most CD28 costimulatory functions in vivo 0.75
Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency 0.01
2 1.91
CLUH Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease 0.91
Detection of Kidney Allograft Rejection Using Urinary Chemokines. 1.00
4 2.34
Complement activation drives a compartmentalized innate immune response in C3 glomerulopathy contributing to the disease phenotype 1.00
Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing 0.72
Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation 0.52
A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications 0.10
1 0.95
Upregulation of adenosine A2A receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficits 0.95
7 0.40
Targeting excessive cholesterol deposition alleviates secondary lymphoedema 0.01
The transition from monocyte to tissue-resident macrophage requires DHPS 0.05
Erythropoietin receptor on cDC1s dictates immune tolerance 0.09
Multi-omics analysis of a pig-to-human decedent kidney xenotransplant 0.01
Physiology and immunology of pig-to-human decedent kidney xenotransplant 0.15
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours 0.06
Rescuing dendritic cell interstitial motility sustains antitumour immunity 0.02
18 8.01
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma 0.03
Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models 0.95
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways 0.04
The genetic driver of Acute Necrotizing Encephalopathy, , regulates the inflammatory response to Influenza A virus infection 0.75
Acute peritonitis-induced adipose CD127 ILC1s express PD-L1 and ameliorate inflammation in mice 0.20
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1 cDC1 infiltration and activates anti-tumor immunity 0.86
Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease 0.04
Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy 1.00
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.11
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection 0.13
Neuron-reactive KIR+CD8+ T cells display an encephalitogenic transcriptional program in autoimmune encephalitis 0.08
Physiologic Homeostasis in a Living Human after Pig Kidney Xenotransplantation 0.02
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features 1.00
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts 0.76
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth 0.08
Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models 0.86
Spatial mapping of innate lymphoid cells in human lymphoid tissues and lymphoma at single-cell resolution 1.00
TRIM23 mediates cGAS-induced autophagy in anti-HSV defense 0.10
13 4.48
IL-9 and Blimp-1 protect the transcriptional identity of group 2 innate lymphocytes in allergic asthma 0.11
Long-term inhibition of protease hypersensitivity by initial immunological cross-regulation and epigenetic memory in lung stromal cells 0.89
Lymphocyte-derived cholinergic circuits modulate germinal center output and B cell activation 0.08
TSLP promotes GATA3-expressing effector regulatory T cells via DC2 derived from transitional DCs 1.00
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function 0.36
Temporal and spatial atlas of eosinophil specialization across tissues 0.13
Adenophages are an atypical macrophage population in exocrine glands sustained by ILC2-derived GM-CSF 0.08
DC subsets and states unraveled across human juxtatumoral and malignant tissues 0.69
Sequential lymphotoxin-β receptor and retinoic acid receptor signals regulate cDC2 fate 0.02
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections 0.97
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor 0.03
Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis 0.03
Transcription factors TCF4 and KLF4 respectively control the development of the DC2A and DC2B lineages 0.10
1 0.64
Genomic and functional adaptations in the guanylate-binding protein 5 highlight specificities of bat antiviral innate immunity 0.64
1 0.07
Structural Design and Immunogenicity of a Novel Self-Adjuvanting Mucosal Vaccine Candidate for SARS-CoV-2 Expressed in Plants 0.07
12 5.62
Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2 0.34
Adhesion forces between macrophages and cancer cells promote early tumor development 0.89
Dual inhibition of mTOR and calcineurin pathways mitigates missing self–induced NK cell–mediated microvascular rejection 0.83
Dynamics of memory B cells and plasmablasts in healthy individuals 0.73
Mapping targetable sites on the human surfaceome for the design of novel binders 0.09
α2-macroglobulin function of thioester-containing proteins guards Drosophila from a bacterial protease via two immune-induced peptides 0.51
T-bet-expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape 0.09
Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy 0.07
Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19 0.51
Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function 1.00
Synovial MS4A4A correlates with inflammation and counteracts response to corticosteroids in arthritis 0.02
Induction of the ISR by AB5 subtilase cytotoxin drives type-I IFN expression in pDCs via STING activation 0.53
1 0.20
Functional characterization of Paillotin: an immune peptide regulated by the Immune deficiency (Imd) pathway with pathogen-specific roles in Drosophila immunity. 0.20
3 1.00
Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation 0.07
Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation 0.09
A human homolog of SIR2 antiphage proteins mediates immunity via the Toll-like receptor pathway 0.84
3 2.04
Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin 1.00
Neonatal regulatory T cells persist into adulthood across multiple tissues with high enrichment in the skin 1.00
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer 0.04
7 3.92
Keratin 16 inhibits type I interferon responses in differentiating keratinocytes of stressed and diseased skin 0.13
Corticosteroid resistance is predetermined by early immune response dynamics at acute graft-versus-host disease onset 1.00
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice 0.94
Follicular regulatory T cells promote experimental autoimmune encephalomyelitis by supporting B cell egress from germinal centers 1.00
Tissue-resident memory CD4+ T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice 0.75
Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes 0.09
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans 0.01
1 0.35
FADD is recruited to activated STING oligomers to initiate caspase-mediated NF-κB activation in Drosophila melanogaster 0.35
7 3.62
Functional assessment of a convergent gene network underlying allergic diseases and IgE 0.53
Soluble FcεRI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation 0.11
Complex Mast Cell CCL2-Chemokine Trafficking Patterns During Local Allergic Responses 0.83
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation 0.08
Late Effects After Haematopoietic Stem Cell Transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP and TCWP EBMT Study 0.21
Regulation of immune cell metabolism by therapeutic normal IgG intravenous immunoglobulin 0.86
The impact of allogeneic hematopoietic stem cell transplantation on pulmonary complications in adults with inborn errors of immunity 1.00
1 0.02
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial 0.02
6 0.54
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine — A Phase 2 Trial 0.29
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia 0.08
Ianalumab plus Eltrombopag in Immune Thrombocytopenia 0.04
Noninferiority of One HPV Vaccine Dose to Two Doses 0.02
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.07
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia 0.06
1 0.01
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.01

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.